English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The insufficient alveolar bone height due to the maxillary sinus in the posterior maxilla and postextraction bone resorption may limit implant placement. The sinus lifting procedure creates space between the maxillary alveolar bone and the Schneiderian membrane, which is filled with graft materials to maintain adequate space for new bone formation. Leucocyteand platelet-rich fibrin (L-PRF)-mixed bone substitute or L-PRF has been used solely as a graft material for sinus lifting. The clinical and radiological findings of the application of PRF for sinus augmentation have been shown to have good results regarding new bone formation. The L-PRF can be an efficient biomaterial for graft particles in maxillary sinus lifting.

Sinus Lifting and Leucocyte- and Platelet-Rich Fibrin